- Filed
- Jun 25, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · Jun 25, 2025 | 113.05M sh |
| Shares Diluted | Q1 2025 · Mar 31, 2025 | 114.29M sh |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 16.79M sh |
| Capex | Q1 2025 · Mar 31, 2025 | $0 |
| Capex | Q1 2025 · Mar 31, 2024 | $5.54K |
| Operating Cash Flow | Q1 2025 · Mar 31, 2025 | −$322.47K |
| Operating Cash Flow restated | Q1 2025 · Mar 31, 2024 | −$515.96K |
| Stockholders Equity | Q1 2025 · Mar 31, 2025 | −$3.38M |
| Stockholders Equity | Q1 2025 · Dec 31, 2024 | −$2.55M |
| Stockholders Equity restated | Q1 2025 · Mar 31, 2024 | −$902.1K |
| Stockholders Equity restated | Q1 2025 · Dec 31, 2023 | −$515.37K |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $5.61M |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $5M |
| Current Assets | Q1 2025 · Mar 31, 2025 | $863.46K |
| Current Assets | Q1 2025 · Dec 31, 2024 | $967.28K |
| Total Assets | Q1 2025 · Mar 31, 2025 | $2.23M |
| Total Assets | Q1 2025 · Dec 31, 2024 | $2.45M |
| Eps Diluted | Q1 2025 · Mar 31, 2025 | −$0.01 |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | −$0.02 |
| Sga Expense | Q1 2025 · Mar 31, 2025 | $1.03M |
| Sga Expense restated | Q1 2025 · Mar 31, 2024 | $240.95K |
| Net Income | Q1 2025 · Mar 31, 2025 | −$1.29M |
| Net Income restated | Q1 2025 · Mar 31, 2024 | −$386.73K |
| Operating Income | Q1 2025 · Mar 31, 2025 | −$949.9K |
| Operating Income restated | Q1 2025 · Mar 31, 2024 | −$262K |
| Gross Profit | Q1 2025 · Mar 31, 2025 | $194.92K |
| Gross Profit restated | Q1 2025 · Mar 31, 2024 | $121.69K |
| Cost Of Revenue | Q1 2025 · Mar 31, 2025 | $877.68K |
| Cost Of Revenue | Q1 2025 · Mar 31, 2024 | $478.85K |
| Revenue | Q1 2025 · Mar 31, 2025 | $1.07M |
| Revenue restated | Q1 2025 · Mar 31, 2024 | $600.54K |